Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-cost fundoscopy simulation for everyone? Evaluation of knowledge gain and student satisfaction with the Kyoto Kagaku model.

Journal francais d'ophtalmologie·2026
Same author

Aniridia-associated keratopathy: Clinical and molecular mechanisms of disease progression and emerging therapeutic targets.

Acta ophthalmologica·2026
Same author

[Home or abroad? Potential effects of political change in Syria on doctors in Germany].

Die Ophthalmologie·2026
Same author

[Excimer laser-assisted keratoplasty is successful in the management of complex cases of intracorneal ring segments in keratoconus].

Die Ophthalmologie·2025
Same author

[Sequential toric IOL implantation after phakic DMEK due to secondary transplant failure after perforating keratoplasty with high corneal astigm].

Die Ophthalmologie·2025
Same author

Subthreshold nanosecond laser therapy for chronic central serous chorioretinopathy: A prospective study.

Journal francais d'ophtalmologie·2025

Related Experiment Video

Updated: Jul 4, 2026

Modeling Cataract Surgery in Mice
05:19

Modeling Cataract Surgery in Mice

Published on: December 1, 2023

[Choroidal effusion after uncomplicated cataract surgery].

I Fromberg1, M Krause, K Brückner

  • 1Augenheilkunde, Gemeinschaftspraxis, St. Wendel. irisfromberg@gmx.de

Klinische Monatsblatter Fur Augenheilkunde
|June 3, 2008
PubMed
Summary

Angiotensin-converting enzyme (ACE) inhibitors may cause delayed angioedema, potentially leading to vision loss after cataract surgery. Preoperative evaluation for angioedema risk is crucial for patient safety.

Related Experiment Videos

Last Updated: Jul 4, 2026

Modeling Cataract Surgery in Mice
05:19

Modeling Cataract Surgery in Mice

Published on: December 1, 2023

Area of Science:

  • Ophthalmology
  • Nephrology
  • Cardiology

Background:

  • Angiotensin-converting enzyme (ACE) inhibitors are associated with delayed angioedema, potentially exacerbated by surgical procedures.
  • Cataract surgery in a patient with hypertension and glomerulonephritis on ACE inhibitors led to postoperative complications.
  • Angioedema can manifest months or years after ACE inhibitor cessation and may be aggravated by local anesthesia.

Observation:

  • A 61-year-old patient developed eye pain and reduced vision post-cataract surgery.
  • Elevated intraocular pressure (28 mmHg) and shallow anterior chamber were noted.
  • Ophthalmoscopy revealed circumferential choroidal and focal exudative retinal detachment.

Findings:

  • Postoperative treatment with antiglaucoma medications, steroids, and antibiotics resolved elevated intraocular pressure and improved vision.
  • Choroidal detachment resolved within two weeks.
  • The patient had a history of minimal change glomerulonephritis and hypertension, treated with low-dose cortisone and an ACE inhibitor (ramipril).

Implications:

  • ACE inhibitor use may be linked to choroidal effusion, a potential cause of vision impairment after ocular surgery.
  • Consider alternative antihypertensive medications preoperatively in patients with a history of angioedema.
  • Glomerulonephritis may contribute to edema; thorough evaluation and treatment are recommended before elective surgery in such patients.